Polymorphism and stability;Polymorphisme et stabilité

S.T.P. Pharma Pratiques

Volumn 14, Issue 3, 2004, Pages 281-291

  Bauer, Michel ^a  

^a SANOFI   (France)

Author keywords

Amorphous phases; Crystalline structures; Hydrates; Polymorphism; Solid solutions; Stability

Indexed keywords

AMPICILLIN; BENZYL THIOCYANATE; CARBAMAZEPINE; PREDNISOLONE;

CRYSTAL STRUCTURE; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG IMPURITY; DRUG MANUFACTURE; DRUG PACKAGING; DRUG STABILITY; HUMIDITY; HYDRATION; PHYSICAL PARAMETERS; REVIEW; SHELF LIFE; SOLID; TEMPERATURE; THEORY;

EID: 4143049274     PISSN: 11571497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Chulia (D.), Deleuil (M.), Pourcelot (Y.), Powder Technology and Pharmaceutical Processes, Elsevier, Amsterdam (1994) (voir en particulier Chapitre 7 - David (R.), Giran (D.), Crystallization, pp. 193-241.
2. Chulia (D.), Deleuil (M.), Pourcelot (Y.), Powder Technology and Pharmaceutical Processes, Elsevier, Amsterdam (1994) (voir en particulier Chapitre 7 - David (R.), Giran (D.), Crystallization, pp. 193-241.
3. Brittain (G.), Polymorphism in Pharmaceutical Solids, Marcel Dekker, Inc. - New York Base (1999).
4. Bernstein (J.), Polymorphism in Molecular Crystals, Clarendow-Oxford Press (2002).
5. Giron (D.), Thermal Analysis and Calorimetric Methods in the Caracterization of Polymorphs and Solvates, Thermochemica Acta, 248, pp 1-59 (1995).
6. Bauer (M.), Le polymorphisme, son origine, ses caractéristiques, ses conséquences dans le domaine pharmaceutique, STP Pharma, 9 (5), pp354-362 (1999).
7. Bauer (M.), La cristallisation des molécules - Conséquences en termes de polymorphisme et faciès appliquées au domaine pharmaceutique - Concepts de base, STP Pharma Pratiques, 13(2), pp47-61 (2003).
8. Bauer (M.), Cristallisation et polymorphisme. Les Techniques de l'Ingénieur (2004) (www.techniques-ingenieur.fr) 7.1 AF3640 - Description du phénomène 7.2 AF3641 - Physico-chimie du polymorphisme 7.3 AF3642 - Application
9. De Villiers (M.M.), Van der Watt (J.G.) et Lötter (A.P.), Kinetic Study of the Solid-State Photolytic Degradation of two Polymorphic forms of Furosemide, International Journal of Pharmaceutics, 88, pp275-283 (1992).
10. Chemburkar (S.R.), Bauer (J.), Deming (K.) and Col., Dealing with the Impact of Ritonavir Polymorphs on the late stages of Bulk Process Development - Organic Process Research and Development, 4, pp413-417 (2000).
11. ICH Guideline Q6A - http://www.emea.eu.int.pdj/human/ich/036796en.pdf.
12. Ali (A.A.) and Farouk (A.), Comparative studies on the bioavailability of ampicillin anhydrate and trihydrate, International Journal of Pharmaceutics, 9, pp239-243 (1981).
13. Kaiho (F.), GOTO (Y.) and Kato (Y.), In vitro release of Prednisolone from oil-in-water type ointment. The effect of crystalline conversion of drug release. Chemical and Pharmaceutical bulletin, 28, pp2240 (1980).
14. Kala (H.), Haak (U.) Wenzel (U.), Zessin (G.) und Pollandt (P.), Zum Kristallographischen Verhalten des Carbamazepins unter Pressdruck, Pharmazie, 42, pp524-527 (1987).
15. Chulia (D.), Polymorphisme, qualités d'usage, test de fonctionnalité. Application à la compression. Colloque polymorphisme et morphologie, Lyon (CPE Lyon Formation continue, contact@cpe-formation.fr, 16-18 déc. 2002).
16. Giron (D.), Le polymorphisme des excipients, STP Pharma, 6, pp87-98 (1990).
17. Hancock (B.C.), Zografi (G.), Characteristics and Significance of the Amorphous State in Pharmaceutical Systems, Journal of Pharmaceutical Sciences, 86, pp1-12 (1997).
18. Hilden (L.R.), Morris (K.R.), Physics of Amorphous Solids, Journal of Pharmaceutical Sciences, 93, pp3-12 (2004).
19. Boutonnet-Fagegaltier (N.), Ménégotto (J.), Lamure (A.), Duplaa (H.), Caron (A.), Lacabanne (C.) et Bauer (M.), Molecular Mobility Study of Amorphous and Crystalline Phases of a Pharmaceutical Product by Thermally Stimulated Current Spectroscopy, Journal of Pharmaceutical Sciences, 91(6), pp1548-1560 (2002).
20. Alié (J.), Ménégotto (J.), Cardon (P.), Duplaa (H.), Caron (A.), Lacabanne (C.) et Bauer (M.), Dielectric Study of the Molecular Mobility and the isothermal Crystallization Kinetics of an Amorphous Pharmaceutical Drug Substance, Journal of Pharmaceutical Sciences, 93(1), pp218-233 (2004).